Rofecoxib (IPA: ) is a nonsteroidal anti-inflammatory drug (NSAID) that was used in the treatment of osteoarthritis, acute pain conditions, and dysmenorrhoea. Formerly marketed by Merck & Co. under the trade names Vioxx, Ceoxx and Ceeoxx, it was voluntarily withdrawn from the market in 2004 because of concerns about increased risk of heart attack and stroke.
Rofecoxib was one of the most widely used drugs ever to be withdrawn from the market. Worldwide, over 80 million people were prescribed rofecoxib at some time. In the year before withdrawal, Merck had a sales revenue of US$2.5 billion from Vioxx.
Rofecoxib was available on prescription as tablets and as an oral suspension.
More on [ Rofecoxib ]
Analgesics and Anti Inflammatories :: Drugs and Medications

Dolib - Product description, prescribing information, clinical studies, abstracts and a discussion board for the Cox-2 in inhibitor rofecoxib.
DrugDigest: Rofecoxib ( Vioxx ) - Information on dosage, usage, side effects, interactions, and drug comparisons, including generics when available.
Spine-Health - Information on Vioxx (Cox 2 inhibitors) and osteoarthritis and back pain.
Meta Description: [ COX-2 inhibitors - Celebrex, a new type of medication for back pain, by Spine-Health. ]
Vioxx.com - Find information on the treatment of osteoarthritis symptoms and pain. For patients and professionals.
| I know I said it but I think it's probably not even correct | |